First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management Journavx is the first drug to be approved in this new class ...
Dr. Roger Hollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in developing gene replacement therapies using blood stem ...
South Texas Blood and Tissue Center (STBT), a subsidiary of San Antonio-based non-profit BioBridge Global and a recognized leader in prehospital transfusion. STBT has made history as the first U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback